Extraction of DNA and RNA from the sample source maximizes the information gained from precious or limited materials, providing an integrated molecular view. It enables researchers to correlate both genomic and transcriptomic data from the cellular matrix, eliminating the problem of sample variability. Omega Bio-tek has developed an innovative nucleic acid extraction methodology (Mag-Bind® DNA/RNA […]
Circulating free DNA (cfDNA) derived from urine has emerged as a promising biomarker in the field of non-invasive diagnostics, particularly in oncology, nephrology, and other areas of medical research. With advances in next-generation sequencing (NGS) and other molecular techniques, such as droplet digital PCR (ddPCR), the analysis of cfDNA from urine holds the potential to
Nucleic acid purification has been Omega Bio-tek’s specialty for 25 years. We are happy to announce our first piece of hardware for research labs isolating DNA samples for downstream analysis. This device offers semi-automatic nucleic acid purification of high-quality DNA and RNA with consistent, repeatable results. Whether you are working with blood, tissues, saliva, swabs,
Introducing the MagBinder Fit24 Read More »
Omega Bio-tek invites you to join us for a live event on December 14th at 10:00 a.m. ET where we will introduce the new standard for high-volume, cost-effective nucleic acid purification. In this event, you will hear from some of our experts, Brandon Easparro, Chris Stuart, and Tesfaye Kemsi, about the MagBinder® Fit24, your ultimate
Webinar December 14th Read More »
Omega Bio-tek invites you to join us for a webinar on October 12th at 2:00 p.m. ET with Omega Bio-tek’s Jeff Roeder and Hamilton’s Michael Vuke. “Streamline your RNA/DNA Purification with Hamilton & Omega Bio-tek” where Jeff and Michael will showcase how Omega Bio-tek and Hamilton can optimize your purification workflows! In this webinar, Jeff
Webinar – Thursday Oct 12 Read More »
Register to Watch This Recording On-Demand High-throughput platforms played an essential role in assisting researchers in maximizing response capacity and meeting exceptional testing demand throughout the course of the COVID-19 pandemic. One such platform, Thermo Fisher Scientific’s KingFisher®, saw a dramatic increase in its utilization across laboratories worldwide due to its ease in automation. This
Register to Watch This Recording On-Demand The use of circulating, cell-free DNA (cfDNA) is rapidly evolving in the clinical landscape and is one of the fastest-growing areas in recent years. It offers tremendous clinical potential as a screening method for tumor, cancer, fetal DNA studies, disease progression, treatment response, and more. Circulating DNA extraction is
To combat a fast-evolving global pandemic like COVID-19, it is essential to develop rapid and accurate diagnostic tests with a quick turnaround time. Recently, saliva has emerged as a viable alternate sample source to nasopharyngeal swabs and has shown to have greater detection sensitivity of SARS-CoV-2, as well as consistency throughout the course of infection.
Saliva as a diagnostic tool for COVID-19 Webinar Read More »
Obtaining high quality and high yielding DNA or RNA is challenging since nucleic acids in FFPE tissue samples are often fragmented and prone to chemical modifications. Co-extraction is beneficial as samples may be limited. While there are many kits to purify either the DNA or RNA from FFPE samples, only a few can purify both
FFPE DNA & RNA Co-Extraction Webinar Read More »
